MRI Features of Histologically Diagnosed Supratentorial Primitive Neuroectodermal Tumors and Pineoblastomas in Correlation with Molecular Diagnoses and Outcomes: A Report from the Children's Oncology Group ACNS0332 Trial

References

1. 1.↵
   2. Rorke LB

   . The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 1983;42:1–15 doi:10.1097/00005072-198301000-00001 pmid:6296325

   CrossRefPubMed
2. 2.↵
   2. Rorke LB,
   3. Trojanowski JQ,
   4. Lee VMY, et al

   . Primitive neuroectodermal tumors of the central nervous system. Brain Pathol 1997;7:765–84 doi:10.1111/j.1750-3639.1997.tb01063.x pmid:9161728

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Jakacki RI,
   3. Burger PC,
   4. Kocak M, et al

   . Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: a report from the Children's Oncology Group. Pediatr Blood Cancer 2015;62:776–83 doi:10.1002/pbc.25405 pmid:25704363

   CrossRefPubMed
4. 4.↵
   2. Pizer BL,
   3. Weston CL,
   4. Robinson KJ, et al

   . Analysis of patients with supratentorial primitive neuro-ectodermal tumors entered into the SIOP/UKCCSG PNET 3 study. Eur J Cancer 2006;42:1120–28 doi:10.1016/j.ejca.2006.01.039 pmid:16632346

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Sturm D,
   3. Orr BA,
   4. Toprak UH, et al

   . New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 2016;164:1060–72 doi:10.1016/j.cell.2016.01.015 pmid:26919435

   CrossRefPubMed
6. 6.↵
   2. Schwalbe EC,
   3. Hayden JT,
   4. Rogers HA, et al

   . Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types. Acta Neuropathol 2013;126:943–46 doi:10.1007/s00401-013-1206-6 pmid:24212602

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Hwang EI,
   3. Kool M,
   4. Burger PC, et al

   . Extensive molecular and clinical heterogeneity in patients with histologically diagnosed CNS-PNET treated as a single entity: a report from the children's oncology group randomized ACNS0332 trial. J Clin Oncol 2018;36:3388–95 doi:10.1200/JCO.2017.76.4720 pmid:30332335

   CrossRefPubMed
8. 8.↵
   2. Louis DN,
   3. Perry A,
   4. Reifenberger G, et al

   . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016;131:803–20 doi:10.1007/s00401-016-1545-1 pmid:27157931

   CrossRefPubMed
9. 9.↵
   2. Pajtler KW,
   3. Witt H,
   4. Sill M, et al

   . Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 2015;27:728–43 doi:10.1016/j.ccell.2015.04.002 pmid:25965575

   CrossRefPubMed
10. 10.↵
    2. Ramaswamy V,
    3. Remke M,
    4. Bouffet E, et al

    . Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 2016;131:821–31 doi:10.1007/s00401-016-1569-6 pmid:27040285

    CrossRefPubMed
11. 11.↵
    2. Kuo MD,
    3. Yamamoto S

    . Next generation radiologic-pathologic correlation in oncology: Rad-Path 2.0. AJR Am J Roentgenol 2011;197:990–97 doi:10.2214/AJR.11.7163 pmid:21940590

    CrossRefPubMed
12. 12.↵
    2. Kuo MD,
    3. Jamshidi N

    . Behind the numbers: decoding molecular phenotypes with radiogenomics–guiding principles and technical considerations. Radiology 2014;270:320–25 doi:10.1148/radiol.13132195 pmid:24471381

    CrossRefPubMed
13. 13.↵
    2. Diehn M,
    3. Nardini C,
    4. Wang DS, et al

    . Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A 2008;105:5213–18 doi:10.1073/pnas.0801279105 pmid:18362333

    Abstract/FREE Full Text
14. 14.↵
    2. Jamshidi N,
    3. Diehn M,
    4. Bredel M, et al

    . Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. Radiology 2014;270:1–2 doi:10.1148/radiol.13130078 pmid:24056404

    CrossRefPubMed
15. 15.↵
    2. Perreault S,
    3. Ramaswamy V,
    4. Achrol AS, et al

    . MRI surrogates for molecular subgroups of medulloblastoma. AJNR Am J Neuroradiol 2014;35:1263–69 doi:10.3174/ajnr.A3990 pmid:24831600

    Abstract/FREE Full Text
16. 16.↵
    2. Nowak J,
    3. Nemes K,
    4. Hohm A, et al

    . Magnetic resonance imaging surrogates of molecular subgroups in atypical teratoid/rhabdoid tumor (ATRT). Neuro Oncol 2018;20:1672–79 doi:10.1093/neuonc/noy111 pmid:30010851

    CrossRefPubMed
17. 17.↵
    2. Karlo CA,
    3. Di Paolo PL,
    4. Chaim J, et al

    . Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations. Radiology 2014;270:464–71 doi:10.1148/radiol.13130663 pmid:24029645

    CrossRefPubMed
18. 18.↵
    2. Capper D,
    3. Jones DTW,
    4. Sill M, et al

    . DNA methylation-based classification of central nervous system tumors. Nature 2018;555:469–74 doi:10.1038/nature26000 pmid:29539639

    CrossRefPubMed
19. 19.↵
    2. Aryee MJ,
    3. Jaffe AE,
    4. Corrada-Bravo H, et al

    . Minfi: a flexible and comprehensive bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 2014;30:1363–69 doi:10.1093/bioinformatics/btu049 pmid:24478339

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Gajjar A,
    3. Pfister SM,
    4. Taylor MD, et al

    . Molecular insights into pediatric brain tumors have the potential to transform therapy. Clin Cancer Res 2014;20:5630–40 doi:10.1158/1078-0432.CCR-14-0833 pmid:25398846

    Abstract/FREE Full Text
21. 21.↵
    2. Zaky W

    . Revisiting management of pediatric brain tumors with new molecular insights. Cell 2016;164:844–46 doi:10.1016/j.cell.2016.02.030 pmid:26919424

    CrossRefPubMed
22. 22.↵
    2. Leary SE,
    3. Olson JM

    . The molecular classification of medulloblastoma: driving the next generation clinical trials. Curr Opin Pediatr 2012;24:33–39 doi:10.1097/MOP.0b013e32834ec106 pmid:22189395

    CrossRefPubMed
23. 23.↵
    2. Sin-Chan P,
    3. Li BK,
    4. Ho B, et al

    . Molecular classification and management of rare pediatric embryonal brain tumors. Curr Oncol Rep 2018;20:69 doi:10.1007/s11912-018-0717-7 pmid:29995179

    CrossRefPubMed
24. 24.↵
    2. Parikh KA,
    3. Venable GT,
    4. Orr BA, et al

    . Pineoblastoma‐the experience at St. Jude Children's Research Hospital. Neurosurgery 2017;81:120–28 doi:10.1093/neuros/nyx005 pmid:28327927

    CrossRefPubMed
25. 25.↵
    2. Chawla A,
    3. Emmanuel JV,
    4. Seow WT, et al

    . Paediatric PNET: pre-surgical MRI features. Clin Radiol 2007;62:43–52 doi:10.1016/j.crad.2006.09.008 pmid:17145263

    CrossRefPubMed
26. 26.↵
    2. Klisch J,
    3. Husstedt H,
    4. Hennings S, et al

    . Supratentorial primitive neuroectodermal tumours: diffusion-weighted MRI. Neuroradiology 2000;42:393–98 doi:10.1007/s002340000318 pmid:10929296

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Nakamura M,
    3. Saeki N,
    4. Iwadate Y, et al

    . Neuroradiological characteristics of pineocytoma and pineoblastoma. Neuroradiology 2000;42:509–14 doi:10.1007/s002349900243 pmid:10952183

    CrossRefPubMed
28. 28.↵
    2. Dai AI,
    3. Backstrom JW,
    4. Burger PC, et al

    . Supratentorial primitive neuroectodermal tumors of infancy: clinical and radiologic findings. Pediatr Neurol 2003;29:430–34 doi:10.1016/S0887-8994(03)00313-8 pmid:14684239

    CrossRefPubMed
29. 29.↵
    2. Fujita A,
    3. Asada M,
    4. Saitoh M, et al

    . Pineoblastoma showing unusual ventricular extension in a young adult: case report. Neurol Med Chir(Tokyo) 1999;39:612–16 doi:10.2176/nmc.39.612 pmid:10487041

    CrossRefPubMed
30. 30.↵
    2. Yuh EL,
    3. Barkovich AJ,
    4. Gupta N

    . Imaging of ependymomas: MRI and CT. Childs Nerv Syst 2009;25:1203–13 doi:10.1007/s00381-009-0878-7 pmid:19360419

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Dumrongpisutikul N,
    3. Intrapiromkul J,
    4. Yousem DM

    . Distinguishing between germinomas and pineal cell tumors on MR imaging. AJNR Am J Neuroradiol 2012;33:550–55 doi:10.3174/ajnr.A2806 pmid:22173760

    Abstract/FREE Full Text
32. 32.↵
    2. Kakigi T,
    3. Okada T,
    4. Kanagaki M, et al

    . Quantitative imaging values of CT, MR, and FDG-PET to differentiate pineal parenchymal tumors and germinomas: are they useful?. Neuroradiology 2014;56:297–303 doi:10.1007/s00234-014-1334-2 pmid:24510202

    CrossRefPubMed
33. 33.↵
    2. Nowak J,
    3. Seidel C,
    4. Pietsch T, et al

    . Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified. Neuro Oncol 2015;17:1157–65 doi:10.1093/neuonc/nov063 pmid:25916887

    CrossRefPubMed